CDK1 in Breast Cancer: Implications for Theranostic Potential
Sepideh Izadi(German Cancer Research Center), Farhad Jadidi‐Niaragh(Tabriz University of Medical Sciences), Afshin Nikkhoo(Tabriz University of Medical Sciences), Mehdi Yousefi(Tabriz University of Medical Sciences), Gholamreza Azizi(Jefferson Hospital for Neuroscience), Afshin Namdar(University of Alberta), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Hamed Mohammadi(Tehran University of Medical Sciences)
Cited by 169
Related Papers
CAR T cells in solid tumors: challenges and opportunities
|Stem Cell Research & Therapy|2021|573
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach
|International Immunopharmacology|2022|384
Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment
|Frontiers in Immunology|2022|363
Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management
|Scandinavian Journal of Immunology|2020|339